ArthroSave
Knee reviving medical services.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
* | €2.6m | Seed | |
| Total Funding | 000k | ||
Related Content
ArthroSave is a medical technology company specializing in the development of innovative treatments for knee osteoarthritis. The company operates in the healthcare sector, targeting patients under the age of 65 who suffer from knee osteoarthritis and are not responding to conservative therapies. ArthroSave's core product, the KneeReviver, is a unique knee joint distraction device designed to unload the damaged knee joint, allowing the tissues to regenerate. This temporary unloading treatment has been studied for over 10 years, demonstrating significant results in knee joint preservation, pain reduction, increased functionality, and postponement of knee replacements.
ArthroSave collaborates closely with orthopedic surgeons, researchers, and patients to ensure the efficacy and safety of its treatments. The company generates revenue through the sale of the KneeReviver device and related medical services. By offering a non-invasive alternative to knee replacement surgery, ArthroSave aims to improve the quality of life for patients suffering from knee osteoarthritis.
Keywords: knee osteoarthritis, KneeReviver, joint distraction, pain reduction, tissue regeneration, orthopedic collaboration, medical technology, non-invasive treatment, knee joint preservation, healthcare innovation.